Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?

INTRODUCTION: Targeting HER2 has improved outcomes in metastatic GE (mGE) cancer. In this study, we aim to explore the feasibility of molecular profiling in patients with refractory mGE cancer in routine clinical practice. METHODS: Archival formalin-fixed, paraffin-embedded (FFPE) samples for patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Mikhail, Sameh, Ciombor, Kristen, Noonan, Anne, Wu, Christina, Goldberg, Richard, Zhao, Weiqiang, Wei, Lai, Mathey, Kristina, Yereb, Melissa, Timmers, Cynthia, Bekaii-Saab, Tanios
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673157/
https://ncbi.nlm.nih.gov/pubmed/26082439
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados